Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 600

Results For "CE"

9352 News Found

Novartis India posts Q4 FY24 net profit lower at Rs. 14.68 Cr
News | May 12, 2024

Novartis India posts Q4 FY24 net profit lower at Rs. 14.68 Cr

Novartis India has reported total income of Rs. 91.59 crores during the period ended March 31, 2024


OMRON Healthcare India and AliveCor partner to improve heart healthcare in India
Healthcare | May 11, 2024

OMRON Healthcare India and AliveCor partner to improve heart healthcare in India

These devices instantly detect various arrhythmias, including atrial fibrillation (Afib), bradycardia, tachycardia, and more


Cipla posts Q4 FY24 consolidated PAT at Rs. 939.04 Cr
News | May 11, 2024

Cipla posts Q4 FY24 consolidated PAT at Rs. 939.04 Cr

The company has posted net profit of Rs. 4,121.55 crores for the Financial Year ended March 31, 2024


Dr. Lal PathLabs posts Q4 FY24 consolidated PAT at Rs. 84.5 Cr
News | May 11, 2024

Dr. Lal PathLabs posts Q4 FY24 consolidated PAT at Rs. 84.5 Cr

The company has posted net profit of Rs.357.7 crores for the Financial Year ended March 31, 2024


Ami Organics posts Q4 FY24 consolidated profit at Rs. 25.14 Cr
News | May 11, 2024

Ami Organics posts Q4 FY24 consolidated profit at Rs. 25.14 Cr

Ami Organics has reported total income of Rs. 226.30 crores during the period ended March 31, 2024


Piramal Pharma posts Q1 FY24 consolidated PAT at Rs. 101.27 Cr
News | May 11, 2024

Piramal Pharma posts Q1 FY24 consolidated PAT at Rs. 101.27 Cr

Piramal Pharma has reported total income of Rs. 2,578.74 crores during the period ended March 31, 2024


Neuland Laboratories posts Q4 FY24 consolidated PAT at Rs. 67.56 Cr
News | May 11, 2024

Neuland Laboratories posts Q4 FY24 consolidated PAT at Rs. 67.56 Cr

Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024


Abbott India posts Q4 FY24 PAT at Rs. 287.06 Cr
News | May 10, 2024

Abbott India posts Q4 FY24 PAT at Rs. 287.06 Cr

The company has posted net profit of Rs. 1,201.22 crores for the Financial Year ended March 31, 2024


Medico Remedies posts Q4 FY24 PAT at Rs. 3.09 Cr
News | May 10, 2024

Medico Remedies posts Q4 FY24 PAT at Rs. 3.09 Cr

The company has posted net profit of Rs.8.29 crores for the Financial Year ended March 31, 2024


Piramal Pharma launches new campaign for 'Polycrol' with Brand Ambassador Jisshu Sengupta
News | May 09, 2024

Piramal Pharma launches new campaign for 'Polycrol' with Brand Ambassador Jisshu Sengupta

the campaign emphasizes the brand's reliability and effectiveness in providing timely relief